15 December 2020 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
9 September 2020 · The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and medical devices work, are safe and of appropriate quality. The…
8 September 2020 · No, the PGD framework does not allow for unlicensed medicines to be supplied and /or administered. For example, imported medicines (e.g. licensed in another country but not…
22 September 2020 · 22 September 2020 13.00 – 14.00 During the Covid emergency, unlicensed and other imported medicines were used as substitutes for critical care licensed medicines to…
8 January 2020 · Exceptions to the general rule for which certain healthcare professionals can sell, supply, and/or administer medicines to patients under Schedule 17 of the Human Medicines…
10 October 2019 · A joint statement from the Neonatal and Paediatric Pharmacists' Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)
2 April 2019 · This document provides guidance and advice which is still relevant to the NHS today, on the application of the licensing provisions of the Medicines Act…
1 August 2018 · This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update…
9 April 2018 · At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee…